Regencell Bioscience Holdings Limited (RGC)

NasdaqCM • Currently up 0.41 (+6.33%) in today's trading session

2 members of Congress have disclosed 10 trades in Regencell Bioscience Holdings Limited (RGC) via STOCK Act filings. The most recent disclosure was a sale by Gary J. Palmer on 12 February 2018. The most active traders have been Gary J. Palmer (6) and Lois Frankel (4). Aggregate disclosed activity totals roughly $32K in purchases and $48K in sales (midpoint estimates from bracketed disclosure amounts).

Regencell Bioscience Holdings Limited is currently trading at $6.89, positioned at 4% of its 52-week range ($4.51 – $69.00).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Claim Free AssetCopy Automatically with eToro

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Past Performance is not an indication of future results.

Current Price
$6.89
24h Change
+0.41 (+6.33%)
52 Week Range
$4.51–$69.00
View on NASDAQ

Regencell Bioscience Holdings Limited Price History and Technical Analysis

Interactive Chart

Congressional Trading Activity for RGC

Select to highlight on chart
5 transactions
Compliance: 20%
Gary J. Palmer12 Feb 201816 Oct 2019SaleStock$1,001 - $15,000N/A
Gary J. Palmer12 Feb 201810 Sept 2019SaleStock$1,001 - $15,000N/A
Lois Frankel9 Jan 201813 May 2019SaleStock$1,001 - $15,000N/A
Lois Frankel8 Jan 201813 May 2019SaleStock$1,001 - $15,000N/A
Lois Frankel8 Dec 20178 Aug 2018SaleStock$1,001 - $15,000N/A

See every trade

Sign in free to see the full trade history for this stock.

Select transactions to view their annotations on the chart

Stock Overview

Market Data

Market Cap

$3.41B

Volume

659.35K

Beta

1.43

P/E Ratio

-485.21

Fundamentals

EPS

$-0.01

Div. Yield

-

Open

$6.43

Day Range

$6.35 – $7.65

Company Information

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NASDAQ · USD
Country
HK
CEO
Yat-Gai Au
IPO Date
2021-07-16
Website
www.regencellbioscience.com

Regencell Bioscience Holdings Limited is a biotechnology firm specializing in Traditional Chinese Medicine (TCM). Its core activities revolve around the research, development, and market introduction of TCM solutions specifically designed to address...

Earnings

Next Report

Q3 2026

28 Oct

EPS Est.

-

Rev. Est.

-

Days Until

51

Recent Quarters

Q1 202615 Jun
EPS$-0.01
Q3 202518 Nov
EPS$-0.00
Q1 202526 Jun
EPS$-0.14
Q3 202425 Oct
EPS$-0.00
Q4 202326 Jan
EPS$0.00
Q3 202327 Oct
EPS$-0.01
Q4 202230 Jan
EPS$-0.01
Q3 202231 Oct
EPS-
Q3 202130 Dec
EPS$-0.01
Q3 202030 Dec
EPS$0.00
Q1 202030 Jun
EPS$0.00
Q3 201930 Dec
EPS$0.00

2 politicians traded within 30 days

Dividends

Dividend History

15 Feb 2018
Amount $0.2200
1 Dec 2017
Amount $0.2200
31 Aug 2017
Amount $0.2200
1 Jun 2017
Amount $0.2200
1 Mar 2017
Amount $0.2200
1 Dec 2016
Amount $0.2200
31 Aug 2016
Amount $0.2200
2 Jun 2016
Amount $0.2200
2 Mar 2016
Amount $0.2200
2 Dec 2015
Amount $0.2200
2 Sept 2015
Amount $0.2200
29 May 2015
Amount $0.2200
27 Feb 2015
Amount $0.2200
2 Dec 2014
Amount $0.2200
3 Sept 2014
Amount $0.2200
30 May 2014
Amount $0.2200
28 Feb 2014
Amount $0.2200
2 Dec 2013
Amount $0.2100
5 Sept 2013
Amount $0.2100
31 May 2013
Amount $0.2100
1 Mar 2013
Amount $0.2100
3 Dec 2012
Amount $0.2100
6 Sept 2012
Amount $0.2100
1 Jun 2012
Amount $0.2100
1 Mar 2012
Amount $0.2100
5 Dec 2011
Amount $0.2100
7 Sept 2011
Amount $0.2100
1 Jun 2011
Amount $0.2100
1 Mar 2011
Amount $0.2100
6 Dec 2010
Amount $0.1800
7 Sept 2010
Amount $0.1800
1 Jun 2010
Amount $0.1800
2 Mar 2010
Amount $0.1800
7 Dec 2009
Amount $0.1800
8 Sept 2009
Amount $0.1800
2 Jun 2009
Amount $0.1800

Stock Splits

Split History

16 Jun 2025Stock Split
Ratio38:1

Similar Stocks

Based on congressional trading patterns

Smart Recommendations
No similar stocks found
No congressional trading patterns available for recommendations

Frequently Asked Questions about RGC

Which members of Congress have traded RGC?
2 members of Congress have disclosed 10 trades in Regencell Bioscience Holdings Limited (RGC) under the STOCK Act. The most active traders are Gary J. Palmer and Lois Frankel.
When was RGC most recently disclosed by Congress?
The most recent RGC disclosure was a sale by Gary J. Palmer on 12 February 2018.
What is the total disclosed congressional trading volume for RGC?
Members of Congress have disclosed approximately $32K in RGC purchases and $48K in sales. These figures are midpoint estimates derived from the bracketed amount ranges used in STOCK Act filings.
How can I track new congressional trades in RGC?
This RGC page updates as soon as new STOCK Act disclosures are filed for Regencell Bioscience Holdings Limited. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Pelosi Tracker
PoliticiansBillsArticlesPortfoliosPricingAboutLegalTerms of ServicePrivacy Policy
Français
© 2026 - All rights reserved. Powered by Vantara Labs
Pelosi Tracker is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office or her representatives, or with any other member of Congress. Any use of her name is solely for the purpose of discussing publicly available information.The information provided by Pelosi Tracker is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.